2022 Q4 Form 10-Q Financial Statement

#000149315222032176 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $752.0K $97.00K $499.0K
YoY Change -2.97% -80.56% 232.67%
Cost Of Revenue $585.0K $17.00K $271.0K
YoY Change 12.93% -93.73% 442.0%
Gross Profit $167.0K $80.00K $228.0K
YoY Change -35.02% -64.91% 128.0%
Gross Profit Margin 22.21% 82.47% 45.69%
Selling, General & Admin $4.896M $955.0K $1.046M
YoY Change 84.62% -8.7% 24.52%
% of Gross Profit 2931.74% 1193.75% 458.77%
Research & Development $283.0K $49.00K $50.00K
YoY Change 146.09% -2.0% -28.57%
% of Gross Profit 169.46% 61.25% 21.93%
Depreciation & Amortization $0.00 $1.000K $0.00
YoY Change -100.0%
% of Gross Profit 0.0% 1.25% 0.0%
Operating Expenses $5.179M $1.004M $1.096M
YoY Change 87.17% -8.39% 21.78%
Operating Profit -$5.012M -$924.0K -$868.0K
YoY Change 99.68% 6.45% 8.5%
Interest Expense -$401.0K -$16.00K
YoY Change 2010.53%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$5.413M -$940.0K -$6.605M
YoY Change 114.04% -85.77% 602.66%
Income Tax $35.00K $15.00K $70.00K
% Of Pretax Income
Net Earnings -$5.448M -$955.0K -$6.675M
YoY Change 120.21% -85.69% 625.54%
Net Earnings / Revenue -724.47% -984.54% -1337.68%
Basic Earnings Per Share -$0.03 -$0.26
Diluted Earnings Per Share -$3.84 -$34.11K -$255.8K
COMMON SHARES
Basic Shares Outstanding 28.00M shares 28.00M shares 26.10M shares
Diluted Shares Outstanding 1.400M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.713M $1.972M $8.599M
YoY Change -64.93% -77.07% 170.41%
Cash & Equivalents $2.713M $1.972M $8.599M
Short-Term Investments
Other Short-Term Assets $100.0K $1.238M $597.0K
YoY Change -56.52% 107.37% 17.06%
Inventory $2.175M $1.553M $201.0K
Prepaid Expenses $612.0K
Receivables $9.000K $226.0K $28.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.609M $4.989M $9.425M
YoY Change -32.76% -47.07% 141.67%
LONG-TERM ASSETS
Property, Plant & Equipment $7.000K $8.000K $26.00K
YoY Change 40.0% -69.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.000K $7.000K $215.0K
YoY Change -84.21% -96.74% 7.5%
Total Long-Term Assets $270.0K $221.0K $241.0K
YoY Change -3.57% -8.3% 20.5%
TOTAL ASSETS
Total Short-Term Assets $5.609M $4.989M $9.425M
Total Long-Term Assets $270.0K $221.0K $241.0K
Total Assets $5.879M $5.210M $9.666M
YoY Change -31.81% -46.1% 135.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $66.00K $41.00K $62.00K
YoY Change -24.14% -33.87% -31.11%
Accrued Expenses $81.00K $28.00K $10.00K
YoY Change 65.31% 180.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.316M $1.715M $266.0K
YoY Change 21.7% 544.74% -26.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $330.0K $341.0K $689.0K
YoY Change -18.72% -50.51% 56.59%
Total Long-Term Liabilities $330.0K $341.0K $689.0K
YoY Change -18.72% -50.51% 46.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.316M $1.715M $266.0K
Total Long-Term Liabilities $330.0K $341.0K $689.0K
Total Liabilities $2.646M $2.056M $955.0K
YoY Change 14.6% 115.29% 13.69%
SHAREHOLDERS EQUITY
Retained Earnings -$62.39M -$60.33M
YoY Change 9.57%
Common Stock $2.000K $28.00K
YoY Change -92.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.233M $3.154M $8.711M
YoY Change
Total Liabilities & Shareholders Equity $5.879M $5.210M $9.666M
YoY Change -31.81% -46.1% 135.76%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$5.448M -$955.0K -$6.675M
YoY Change 120.21% -85.69% 625.54%
Depreciation, Depletion And Amortization $0.00 $1.000K $0.00
YoY Change -100.0%
Cash From Operating Activities -$1.331M -$1.964M -$634.0K
YoY Change 54.23% 209.78% -8.12%
INVESTING ACTIVITIES
Capital Expenditures -$1.000K -$2.000K -$1.000K
YoY Change 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $1.000K -$2.000K -$1.000K
YoY Change 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.092M 0.000 3.562M
YoY Change -100.0% -11.61%
NET CHANGE
Cash From Operating Activities -1.331M -1.964M -634.0K
Cash From Investing Activities 1.000K -2.000K -1.000K
Cash From Financing Activities 2.092M 0.000 3.562M
Net Change In Cash 762.0K -1.966M 2.927M
YoY Change -188.3% -167.17% -12.37%
FREE CASH FLOW
Cash From Operating Activities -$1.331M -$1.964M -$634.0K
Capital Expenditures -$1.000K -$2.000K -$1.000K
Free Cash Flow -$1.330M -$1.962M -$633.0K
YoY Change 54.11% 209.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001326706
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2022Q3 NAOV Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
usd
CY2021Q3 NAOV Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
usd
NAOV Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
usd
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
NAOV Shares Issued From Exercise Of Warrants Previously Classified As Derivative Liability
SharesIssuedFromExerciseOfWarrantsPreviouslyClassifiedAsDerivativeLiability
usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
usd
NAOV Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022Q3 NAOV Warrant Modification Expense
WarrantModificationExpense
usd
CY2021Q3 NAOV Warrant Modification Expense
WarrantModificationExpense
usd
NAOV Warrant Modification Expense
WarrantModificationExpense
usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
NAOV Warrant Modification Expense
WarrantModificationExpense
usd
NAOV Reclass Liability To Equity After Increase In Authorized Shares
ReclassLiabilityToEquityAfterIncreaseInAuthorizedShares
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36445
dei Entity Registrant Name
EntityRegistrantName
NanoVibronix, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0801232
dei Entity Address Address Line1
EntityAddressAddressLine1
525 Executive Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Elmsford
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10523
dei City Area Code
CityAreaCode
(914)
dei Local Phone Number
LocalPhoneNumber
233-3004
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
NAOV
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27997793 shares
CY2022Q3 us-gaap Cash
Cash
1972000 usd
CY2021Q4 us-gaap Cash
Cash
7737000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
226000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
200000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1238000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
230000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1553000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
175000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
4989000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8342000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
221000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
280000 usd
CY2022Q3 us-gaap Assets
Assets
5210000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19000 usd
CY2022Q3 NAOV Severance Assets Noncurent
SeveranceAssetsNoncurent
178000 usd
CY2021Q4 NAOV Severance Assets Noncurent
SeveranceAssetsNoncurent
207000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49000 usd
CY2021Q4 us-gaap Assets
Assets
8622000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
41000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
87000 usd
CY2022Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1646000 usd
CY2021Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1723000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
44000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
28000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
49000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1715000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1903000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
222000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
253000 usd
CY2022Q3 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
119000 usd
CY2021Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
153000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
2056000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2309000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27997793 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27997793 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27997793 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27997793 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
28000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63449000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63162000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
60000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60326000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56937000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3154000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6313000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5210000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8622000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
499000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
854000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
920000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
17000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
271000 usd
us-gaap Cost Of Revenue
CostOfRevenue
387000 usd
us-gaap Cost Of Revenue
CostOfRevenue
407000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
80000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
228000 usd
us-gaap Gross Profit
GrossProfit
467000 usd
us-gaap Gross Profit
GrossProfit
513000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
176000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
178000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
217000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
245000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
760000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
852000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
738000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
801000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2835000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2656000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1004000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1096000 usd
us-gaap Operating Expenses
OperatingExpenses
3771000 usd
us-gaap Operating Expenses
OperatingExpenses
3686000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-924000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-868000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3304000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3173000 usd
CY2022Q3 NAOV Financial Expenses Net
FinancialExpensesNet
-16000 usd
CY2021Q3 NAOV Financial Expenses Net
FinancialExpensesNet
-23000 usd
NAOV Financial Expenses Net
FinancialExpensesNet
-47000 usd
NAOV Financial Expenses Net
FinancialExpensesNet
-29000 usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5714000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-6956000 usd
NAOV Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
64000 usd
NAOV Warrant Modification Expense
WarrantModificationExpense
1627000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-940000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6605000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3351000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11721000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
70000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-955000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6675000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3389000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11808000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27997793 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26096957 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27997793 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25014919 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-955000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6675000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3389000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11808000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
6000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
57000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
7000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-999000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6674000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3446000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11815000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4164000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
35000 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3558000 usd
CY2021Q3 NAOV Adjustments To Additional Paid In Capital Reclass From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassFromLiabilityToEquity
7626000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6675000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
8711000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2394000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
114000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7052000 usd
NAOV Adjustments To Additional Paid In Capital Reclass From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassFromLiabilityToEquity
10963000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11808000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
8711000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4134000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
116000 usd
CY2022Q3 NAOV Adjustments To Additional Paid In Capital Reversal Of Warrants
AdjustmentsToAdditionalPaidInCapitalReversalOfWarrants
135000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-955000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3154000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6313000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
287000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
135000 usd
NAOV Adjustments To Additional Paid In Capital Reversal Of Warrants
AdjustmentsToAdditionalPaidInCapitalReversalOfWarrants
135000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-57000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3389000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3154000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3389000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11808000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
287000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
114000 usd
NAOV Warrant Modification Expense
WarrantModificationExpense
1627000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-12000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-9000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-7148000 usd
NAOV Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
64000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1008000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
330000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1378000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
56000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-46000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-82000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-77000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-294000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-78000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
237000 usd
NAOV Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
-2000 usd
NAOV Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
-2000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5704000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3504000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4968000 usd
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
388000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4580000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-57000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-7000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5765000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1066000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7737000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7533000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1972000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8599000 usd
NAOV Shares Issued From Exercise Of Warrants Previously Classified As Derivative Liability
SharesIssuedFromExerciseOfWarrantsPreviouslyClassifiedAsDerivativeLiability
2087000 usd
NAOV Reclass Liability To Equity After Increase In Authorized Shares
ReclassLiabilityToEquityAfterIncreaseInAuthorizedShares
10963000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80C_eus-gaap--NatureOfOperations_zJm9aqIqt8Ri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_821_zYvhGAh3sNd1">DESCRIPTION OF BUSINESS</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix, Inc. (the “Company”), a Delaware corporation, commenced operations on October 20, 2003 and is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy and can be administered at home, without the assistance of medical professionals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s principal research and development activities are conducted in Israel through its wholly owned subsidiary, NanoVibronix (Israel 2003) Ltd., a company registered in Israel, which commenced operations in October 2003.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5704000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1972000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zViTnwcsj6nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company believe that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
57000 usd
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
7000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.45
CY2021Q3 us-gaap Share Price
SharePrice
1.04
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.45
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0358 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0049 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.253 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.815 pure
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
116000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
99000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
287000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
306000 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
250000 shares
CY2022Q2 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2029-06-14
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
135000000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
250000 shares
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
135000000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P7Y
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5286846 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4224199 shares
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
499000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
854000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
920000 usd
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.19
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
12000 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7 usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19000 usd

Files In Submission

Name View Source Status
0001493152-22-032176-index-headers.html Edgar Link pending
0001493152-22-032176-index.html Edgar Link pending
0001493152-22-032176.txt Edgar Link pending
0001493152-22-032176-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
naov-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
naov-20220930_cal.xml Edgar Link unprocessable
naov-20220930_def.xml Edgar Link unprocessable
naov-20220930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
naov-20220930_pre.xml Edgar Link unprocessable